Literature DB >> 1319273

Glial fibrillary acidic protein (GFAP) expression and nucleolar organizer regions (NORs) in human gliomas.

K Kajiwara1, T Orita, T Nishizaki, T Kamiryo, H Nakayama, H Ito.   

Abstract

The frequency of nucleolar organizer regions (NORs) in each glioma tissue and the relation between the expression of glial fibrillary acidic protein (GFAP) and the frequency of NORs was investigated. The number of Ag-NORs per cell for glioblastoma multiforme was significantly higher than that for anaplastic astrocytoma (P less than 0.05) and that for astrocytoma (P less than 0.01). The number of Ag-NORs per cell for GFAP-positive cells was significantly lower than that for GFAP-negative cells in each histopathological grade (P less than 0.01). Moreover, the linear relationship was demonstrated between the Ag-NORs numbers of GFAP-negative cells and bromodeoxyuridine (BUdR) labeling indices. From these results, it is concluded that many GFAP-positive glioma cells may have low growth potential in glioma tissue and GFAP-negative cells may have a close relation to cell proliferation. The combination of immunohistochemical and silver colloid staining is a useful method for investigating the biological characteristics of brain tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319273     DOI: 10.1016/0006-8993(92)90492-r

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Alteration in p53 modulates glial proteins in human glial tumour cells.

Authors:  H S U; A Banaie; L Rigby; J Chen; H Meltzer
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

2.  PDGFR inhibition mediated intracellular signalling in C6 glioma growth and migration: role of ERK and ROCK pathway.

Authors:  Juhi Singh; Kedarlal Sharma; Prakash P Pillai
Journal:  Cytotechnology       Date:  2017-11-15       Impact factor: 2.058

3.  Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells.

Authors:  Takao Nakagawa; Toshihiko Kubota; Kazunori Ido; Takahiro Sakuma; Ken Matsuda
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

4.  Establishment and partial characterization of a human tumor cell line, GBM-HSF, from a glioblastoma multiforme.

Authors:  Jiagui Qu; Joshua D Rizak; Yaodong Fan; Xiaoxuan Guo; Jiejing Li; Tanzeel Huma; Yuanye Ma
Journal:  Hum Cell       Date:  2014-01-04       Impact factor: 4.174

Review 5.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 6.  Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.

Authors:  Manali Tilak; Jennifer Holborn; Laura A New; Jasmin Lalonde; Nina Jones
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

7.  Importance of GFAP isoform-specific analyses in astrocytoma.

Authors:  Emma J van Bodegraven; Jessy V van Asperen; Pierre A J Robe; Elly M Hol
Journal:  Glia       Date:  2019-01-22       Impact factor: 7.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.